Latest News and Press Releases

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition ageBrigham and Women’s Hospital...

Idorsia receives approval from Health Canada for JERAYGO™ (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral...

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced distribution dates for the 21shares...

Canton of Zug, Switzerland and Singapore – December 29, 2025 - WISeKey International Holding AG (Nasdaq: WKEY) (“WISeKey”) , a global leader in cybersecurity, digital identity, and IoT solutions...

GAM Fund managers publish open letter on Yutaka Giken tender offer, citing low premium and net-cash undervaluation, urging transparency and a higher price.

Three new projects in India will bring the Company’s global renewable energy capacity to 3.3GW 22 December 2025, 08:30 CET ArcelorMittal (‘the Company’) today announces three new renewable energy...

Geneva, Switzerland, December 22, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today issued a Letter to...

Clariant rejects allegations from MOL Group and Braskem against four companies related to the 2020 competition law infringement

Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences Approval...

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company...